| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041057413 |
| P356 | DOI | 10.1038/SJ.BJC.6605846 |
| P932 | PMC publication ID | 2965861 |
| P698 | PubMed publication ID | 20808308 |
| P5875 | ResearchGate publication ID | 46108056 |
| P50 | author | Lewis C. Cantley | Q5017731 |
| Edward L. Giovannucci | Q20740896 | ||
| Massimo Loda | Q63146189 | ||
| P2093 | author name string | J A Engelman | |
| A T Chan | |||
| C S Fuchs | |||
| J A Meyerhardt | |||
| Y Baba | |||
| S Ogino | |||
| K Shima | |||
| K Nosho | |||
| P2860 | cites work | Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. | Q27851408 |
| Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis | Q28246808 | ||
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF | Q28474973 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| Metformin and reduced risk of cancer in diabetic patients | Q29616275 | ||
| Hyperactive Ras in developmental disorders and cancer | Q29616397 | ||
| The LKB1-AMPK pathway: metabolism and growth control in tumour suppression | Q29617506 | ||
| Insulin and insulin-like growth factor signalling in neoplasia | Q29619495 | ||
| LKB1 modulates lung cancer differentiation and metastasis | Q30080027 | ||
| Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms | Q30946240 | ||
| Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample | Q33383866 | ||
| Histological evaluation of AMPK signalling in primary breast cancer | Q33499119 | ||
| Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells | Q33525767 | ||
| Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients | Q33620070 | ||
| Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status | Q33620091 | ||
| AMP-activated protein kinase antagonizes pro-apoptotic extracellular signal-regulated kinase activation by inducing dual-specificity protein phosphatases in response to glucose deprivation in HCT116 carcinoma | Q33825016 | ||
| Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma | Q33834425 | ||
| Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes | Q33996409 | ||
| Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer | Q35082216 | ||
| CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies | Q35760749 | ||
| Sensitive sequencing method for KRAS mutation detection by Pyrosequencing | Q35789986 | ||
| CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations | Q35807863 | ||
| Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample | Q35855515 | ||
| Raf: a strategic target for therapeutic development against cancer | Q36260492 | ||
| Molecular classification and correlates in colorectal cancer | Q36329300 | ||
| Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer | Q36616070 | ||
| PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. | Q36661711 | ||
| LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. | Q37070832 | ||
| Cohort study of fatty acid synthase expression and patient survival in colon cancer | Q37071671 | ||
| A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer | Q37090752 | ||
| Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment | Q37134137 | ||
| CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer | Q37185561 | ||
| Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis | Q37228454 | ||
| High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer | Q37228483 | ||
| SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. | Q37246556 | ||
| Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation | Q37274568 | ||
| KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. | Q37330719 | ||
| Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis | Q37401531 | ||
| Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer | Q37424106 | ||
| Energy homeostasis and cancer prevention: the AMP-activated protein kinase | Q37428423 | ||
| AMPK: Evidence for an energy-sensing cytokinetic tumor suppressor | Q39785261 | ||
| KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer | Q39860040 | ||
| Inhibition of AMP-activated protein kinase sensitizes cancer cells to cisplatin-induced apoptosis via hyper-induction of p53. | Q40035672 | ||
| Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth | Q40105523 | ||
| Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway | Q40819187 | ||
| The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase | Q46166123 | ||
| Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin | Q46917157 | ||
| Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. | Q51597972 | ||
| Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas | Q51716801 | ||
| Mitotic kinase dynamics of the active form of AMPK (phospho-AMPKalphaThr172) in human cancer cells | Q51817801 | ||
| Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells | Q53340964 | ||
| Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma | Q53603188 | ||
| Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. | Q55469941 | ||
| Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations | Q79408938 | ||
| Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component | Q81105482 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 1025-1033 | |
| P577 | publication date | 2010-08-31 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer | |
| P478 | volume | 103 |
| Q92286756 | A Review on Dietary Intervention in Obesity Associated Colon Cancer |
| Q54522229 | AMPK and GCN2–ATF4 signal the repression of mitochondria in colon cancer cells |
| Q92082272 | ATP Synthase Subunit Epsilon Overexpression Promotes Metastasis by Modulating AMPK Signaling to Induce Epithelial-to-Mesenchymal Transition and Is a Poor Prognostic Marker in Colorectal Cancer Patients |
| Q36088484 | An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps |
| Q47920725 | Arctii Fructus Inhibits Colorectal Cancer Cell Proliferation and MMPs Mediated Invasion via AMPK. |
| Q36927955 | Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells |
| Q47996715 | Association between Phosphorylated AMP-Activated Protein Kinase and MAPK3/1 Expression and Prognosis for Patients with Gastric Cancer |
| Q35858819 | Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. |
| Q39093766 | Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of metformin in phosphatase and tensin homolog-deficient RAW264.7 cells |
| Q33800268 | Caffeic acid derivatives inhibit the growth of colon cancer: involvement of the PI3-K/Akt and AMPK signaling pathways |
| Q92097837 | Cannabinoid Signaling in Cancer |
| Q90290566 | Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico |
| Q42353389 | Diet-induced alteration of fatty acid synthase in prostate cancer progression |
| Q37543714 | Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. |
| Q28081491 | Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies |
| Q92446005 | Energy Restriction and Colorectal Cancer: A Call for Additional Research |
| Q85076808 | Expression of EGFR, HER2, phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients |
| Q41178228 | Expression of cholecystokinin receptors in colon cancer and the clinical correlation in Taiwan |
| Q93147777 | Expression of p-AMPK in colorectal cancer revealed substantial diverse survival patterns |
| Q58583038 | Galla Rhois water extract inhibits lung metastasis by inducing AMPK‑mediated apoptosis and suppressing metastatic properties of colorectal cancer cells |
| Q64286509 | Gene expression profile analysis of colon cancer grade II into grade III transition by using system biology |
| Q34389503 | Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses |
| Q53278287 | Immunohistochemical Analysis of mTOR Activity in Tissues |
| Q29303134 | Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells |
| Q37231995 | Metformin use and improved response to therapy in rectal cancer |
| Q24620628 | Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field |
| Q24289344 | Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease |
| Q37139174 | Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention |
| Q39473711 | Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology |
| Q54485754 | Phosphorylated AMP-activated protein kinase expression associated with prognosis for patients with gastric cancer treated with cisplatin-based adjuvant chemotherapy |
| Q33877467 | Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab |
| Q36157437 | Prognostic significance of AMPK in human malignancies: A meta-analysis |
| Q42292545 | Quantitative assessment of short amplicons in FFPE-derived long-chain RNA. |
| Q53584232 | Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines. |
| Q49829650 | Rosmarinic Acid Activates AMPK to Inhibit Metastasis of Colorectal Cancer |
| Q35781311 | Targeting AMPK for cancer prevention and treatment |
Search more.